Dare Bioscience, Inc. Selling, General and Administrative Expense
Dare Bioscience, Inc. (DARE) reported Selling, General and Administrative Expense of $2.59 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-13
- Dare Bioscience, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $2.59M, a 9.08% increase year-over-year.
- Dare Bioscience, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $2.25M, a 2.62% decline year-over-year.
- Dare Bioscience, Inc. selling, general and administrative expense for the quarter ending 2025-06-30 was $2.38M.
- Dare Bioscience, Inc. selling, general and administrative expense for the quarter ending 2025-03-31 was $2.31M.
- Dare Bioscience, Inc. selling, general and administrative expense for fiscal 2025 was $8.76M, a 4.29% decline from fiscal 2024.
- Dare Bioscience, Inc. selling, general and administrative expense for fiscal 2024 was $9.16M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|
| 2026-06-30 | $2.59M 10-Q · filed 2026-08-13 | $4.84M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $2.25M 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | $8.76M 10-K · filed 2026-03-26 | ||
| 2025-06-30 | $2.38M 10-Q · filed 2026-08-13 | $4.69M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $2.31M 10-Q · filed 2026-05-14 | ||
| 2024-12-31 | $9.16M 10-K · filed 2026-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |